Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News | Stents Bifurcation

October 2, 2015 — Tryton Medical Inc. announced that results of a post hoc analysis of the pivotal Tryton Randomized ...

Home October 02, 2015
Home
News | Stents Peripheral

October 1, 2015 — Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two ...

Home October 01, 2015
Home
News | Stents Peripheral

October 1, 2015 — Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the ...

Home October 01, 2015
Home
News | Stents Peripheral

September 28, 2015 — New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific ...

Home September 28, 2015
Home
News | Stents

September 23, 2015 — CeloNova BioSciences Inc. announced that it has received conditional approval to start an ...

Home September 23, 2015
Home
ABSORB STEMI TROFI II trial, ESC 2015, bioresorbable vascular scaffold, BVS, STEMI patients
Feature | Stents Bioresorbable

September 4, 2015 — A drug-eluting coronary stent made of absorbable material performed similarly to gold-standard metal ...

Home September 04, 2015
Home
News | Stents Bioresorbable

September 1, 2015 — A bioresorbable drug-eluting coronary stent showed similar efficacy and safety results compared to a ...

Home September 01, 2015
Home
News | Peripheral Artery Disease (PAD)

August 28, 2015 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania and second in the ...

Home August 28, 2015
Home
News | Cath Lab

August 27, 2015 — The use of computational fluid dynamics (CFD) modeling has been used for years to better engineer ...

Home August 27, 2015
Home
News | Cath Lab

August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...

Home August 26, 2015
Home
Technology | Stents Peripheral

August 20, 2015 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Innova ...

Home August 20, 2015
Home
News | Cath Lab

August 17, 2015 — The global interventional cardiology devices market is expected to reach $25.16 billion by 2020 ...

Home August 17, 2015
Home
News | Stents Bioresorbable

August 5, 2015 — The global market value for bioabsorbable scaffolds (BAS) will expand rapidly from $143.7 million in ...

Home August 05, 2015
Home
European interventional cardiology market, drug-eluting stents, Abbott Laboratories, Boston Scientific, Medtronic
Feature | Stents

July 31, 2015 — According to a new report on the Europe market for interventional cardiology by iData Research, drug ...

Home July 31, 2015
Home
Boston Scientific, fully absorbable scaffold, FAST study, resorbable
Feature | Stents Bioresorbable

July 20, 2015 - Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold ...

Home July 20, 2015
Home
Subscribe Now